Arrowstreet Capital’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-105,777
Closed -$1.21M 2688
2020
Q4
$1.21M Buy
105,777
+74,403
+237% +$848K ﹤0.01% 1765
2020
Q3
$216K Buy
+31,374
New +$206K ﹤0.01% 2189
2018
Q4
Sell
-20,050
Closed -$434K 1578
2018
Q3
$434K Buy
+20,050
New +$379K ﹤0.01% 917

Arrowstreet Capital's ARA Position: Q1 2021 in Review

Arrowstreet Capital sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 105,777 shares — an estimated $1.21M sold.

Arrowstreet Capital first reported a position in ARA in Q3 2018 and held it in 3 quarters. The position peaked at $1.21M in Q4 2020. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • Arrowstreet Capital reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 105,777 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $1.21M.
  • Arrowstreet Capital first reported a position in American Renal Associates Holdings, Inc in Q3 2018 and held it in 3 quarters.
  • Arrowstreet Capital's American Renal Associates Holdings, Inc position peaked at $1.21M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.